ClinicalTrials.Veeva

Menu

Factors Related to the Progression of Chronic Kidney Disease

A

Ankara Education and Research Hospital

Status

Unknown

Conditions

Chronic Kidney Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01317173
NEPH001

Details and patient eligibility

About

Chronic kidney disease is a progressive disorder that has been influenced with many factors. Most of the patients has altered Ca P metabolism and these dis orders are the contributing factors of the disease progression. It has been recently documented that FGF23 and Klotho are the key factors of PTH secretion Ca-P metabolism. This study aimed to evaluate the impact of Klotho and FGF23 on the progression of stage 3-4 chronic kidney disease.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Non-diabetic chronic kidney disease

Exclusion criteria

  • Presence of DM
  • Actively using calcium based phosphorus binder of vitamin D

Trial design

90 participants in 2 patient groups

Progressive disease
Description:
Serum creatinin level rise more than 2 times
Non-progressive disease
Description:
Serum creatinin level rise less than 2 times

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems